{"article": [{"url": "https://www.marketwatch.com/story/bds-stock-gains-on-launch-of-rapid-covid-19-diagnostic-test-2020-07-06", "published": 1594021880.0, "headline": "BD's stock gains on launch of rapid COVID-19 diagnostic test", "body": "Shares of Becton Dickinson & Co. BDX, +0.46% gained 3.6% in premarket trading on Monday after the diagnostics company announced the launch of a point-of-care COVID-19 antigen test that can detect the coronavirus in 15 minutes. It's the third BD COVID-19 diagnostic test to receive emergency use authorization from the Food and Drug Administration during the pandemic. \"This will be a game-changer for frontline health care workers and their patients to be able to access a quick diagnostic test for COVID-19, offering results in real-time at convenient locations like retail pharmacies, urgent care centers and doctors' offices,\" Dave Hickey, president of BD's integrated diagnostic solutions business, said in a news release. BD's stock is down 9.9% year-to-date, while the S&P 500 SPX, +0.87% has declined 3.1%."}]}